Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
-
Narrated by:
-
By:
About this listen
Featuring a slide presentation from Dr Matthew Matasar and related discussion from Dr Carla Casulo, Dr Matasar and Dr Laurie H Sehn, including the following topics:
- EZH2 Inhibitors for Follicular Lymphoma (FL) (0:00)
- Bruton Tyrosine Kinase Inhibitors for FL (5:43)
- Anti-CD19 Antibodies for FL (9:40)
- Other Novel Agents Under Clinical Development for FL (18:50)
- Case: A woman in her early 80s with multiple comorbidities and relapsed FL (23:06)
- Case: A man in his early 40s with high-risk progressive FL that did not achieve deep remission with prior therapy (27:07)
- Case: A woman in her early 70s with rheumatoid arthritis and relapsed FL (33:46)
CME information and select publications
What listeners say about Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.